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Abstract
Objectives Cardiomyopathy is a key factor in accelerated car-
diovascular mortality in haemodialysis (HD) patients. We
aimed to phenotype cardiac and vascular dysfunction by tagged
cardiovascular magnetic resonance (CMR) imaging in patients
recently commencing HD.
Methods Fifty-four HD patients and 29 age and sex-matched
controls without kidney disease were studied. Left ventricular
(LV) mass, volumes, ejection fraction (EF), concentric remod-
elling, peak-systolic circumferential strain (PSS), peak diastolic
strain rate (PDSR), LV dyssynchrony, aortic distensibility and
aortic pulse wave velocity were determined.
Results Global systolic function was reduced (EF 51±10%, HD
versus 59±5%, controls, p<0.001; PSS 15.9±3.7% versus 19.5
±3.3%, p<0.001). Diastolic function was decreased (PDSR 1.07
±0.33s-1 versus 1.31±0.38s-1, p=0.003). LV mass index was
increased (63[54,79]g/m2 versus 46[42,53]g/m2, p<0.001).
Anteroseptal reductions in PSS were apparent. These abnormal-
ities remained prevalent in the subset of HD patients with
preserved EF >50% (n=35) and the subset of HD patients
without diabetes (n=40). LV dyssynchrony was inversely
correlated to diastolic function, EF and aortic distensibili-
ty. Diastolic function was inversely correlated to LV
dyssynchrony, concentric remodelling, age and aortic
pulse wave velocity.
Conclusion Patients new to HD have multiple cardiac and aor-
tic abnormalities as characterised by tagged CMR. Cardio-
protective interventions are required from initiation of therapy.
Key Points
• First characterisation of cardiomyopathy by tagged CMR in
haemodialysis patients.
• Diastolic function was correlated to LV dyssynchrony, con-
centric remodelling and aortic PWV.
• Reductions in strain localised to the septal and anterior wall.
• Bioimpedance measures were unrelated to LV strain, sug-
gesting volume-independent pathogenetic mechanisms.
• Multiple abnormalities persisted in the HD patient subset
with preserved EF or without diabetes.
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Introduction
Abnormal cardiac and vascular structure and function play
a key part in excessive cardiovascular events and prema-
ture mortality experienced by patients with end-stage renal
disease using haemodialysis (HD). This cannot wholly be
attributed to the high burden of atherosclerotic risk fac-
tors. Factors specific to chronic kidney disease (CKD)
such as anaemia, hyperphosphatemia and vascular calcifi-
cation are well-recognized to cause left ventricular dilata-
tion and hypertrophy [1]. It is also known that the HD
procedure itself contributes to development of cardiomy-
opathy by inducing hypotension and cardiac ischemia, as
detected by early transient reductions in ventricular defor-
mation that precede global dysfunction and increased mor-
tality. Drug-based therapies that reduce cardiovascular
morbidity in the CKD population have been ineffective
in those using HD [2]. The development of cardiomyopa-
thy might be prevented by early application of HD-based
interventions such as cool dialysate or an extended length
of HD treatment [3, 4].
Adverse changes in left ventricular (LV) geometry and
function after cardiac injury are termed remodelling. At a
cellular level, remodelling is characterised by cardiomyo-
cyte hypertrophy, interstitial fibrosis, apoptosis and capil-
lary rarefaction. Cardiovascular magnetic resonance
(CMR) imaging is the reference standard technique for
analysis of LV mass, volumes and geometry. The LV
mass-to-volume ratio indexes LV wall thickness to cavity
size, categorizing LV geometry as concentric remodelling,
concentric hypertrophy or eccentric hypertrophy. The type
of geometry has been noted to prognosticate cardiovascu-
lar risk beyond that by LV hypertrophy alone in HD pa-
tients and large general population studies [5, 6]. In addi-
tion, CMR images of the left ventricle (LV) can be mag-
netically ‘tagged’ with a grid pattern. The motion of these
tags can be tracked by software to quantify the magnitude
(strain) and velocity (strain rate) of tissue deformation,
providing an earlier marker of LV dysfunction than the
ejection fraction (EF) [7].
Prior CMR data reported HD patients with several years
of exposure to HD, using gadolinium contrast media that
are now contraindicated for patients with impaired kidney
function. Such studies are limited by prevalence-incidence
bias which is particularly relevant as mortality within the
first 6 months of starting HD is markedly increased [8].
There are few studies in patients new to HD using indices
that might detect abnormalities earlier, such as strain or
dyssynchrony [9]. We aimed to phenotype cardiac
abnormalities in an unselected incident HD population
with non-contrast tagged CMR to determine the character-
istics and severity of HD-associated cardiomyopathy in the
early phase of a patient’s time using HD.
Materials and methods
Subjects
This multi-centre study was approved by the institutional re-
view board and conducted in accordance with the Declaration
of Helsinki. All participants gave written informed consent.
The HD patients were recruited from four geographically local
university teaching hospitals as part of a clinical trial of an
intervention to prevent cardiomyopathy, with these data ac-
quired prior to any trial interventions. Inclusion criteria were:
1. Age ≥16 years
2. Having HD treatment three times per week.
3. Willing and able to provide consent.
4. Exposure to haemodialysis for ≤180 days.
Exclusion criteria were:
1. Contraindications for CMR
2. Inability to tolerate CMR due to claustrophobia
3. New York Heart Association grade IV heart failure
4. Pregnancy or lactating
5. Mental incapacity to consent
Healthy volunteers were recruited through a local clinical
research volunteer program. Their inclusion criteria were:
1. Age ≥16 years.
2. Willing and able to provide consent.
Exclusion criteria were:
1. Contraindications for CMR
2. Inability to tolerate CMR due to claustrophobia
3. History of kidney disease, heart disease or cardiomy-
opathy
4. Mental incapacity to consent
HD characteristics
Patients were treated with in-centre HD treatments three times
per week, with treatment times of 3.5–4 hours using low-flux
dialyzers (LOPS 18/20; Braun Medical Ltd, Sheffield, UK).
Dialysate temperature was 36–37 °C. Dialysate composition
was sodium 136–138 mmol/l; potassium 2 mmol/l; calcium
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1.25 mmol/l; magnesium 0.5 mmol/l; bicarbonate 32–38
mmol/l; glucose 5.6 mmol/l and acetate 3 mmol/l. Dialysate
flow rate was 500 mL/min and blood pump speed was 250–
450 mL/min using anticoagulation by unfractionated heparin.
Dry weight was prescribed by the clinical team according to
local protocol to achieve an equilibrated Kt/Vurea >1.1 and
standardized Kt/Vurea of >2.0.
Data collection
Imaging by CMR was timed on a midweek post-dialysis day
avoiding the long break in dialysis after the weekend, when
patients are most hypervolemic [10]. Studies were conducted
using a 1.5-Tesla scanner (GE Signa HDxt, GE Healthcare,
Milwaukee, USA) with an 8-channel phased-array receiver
coil, 12–20-second end-expiratory breath-holds and retrospec-
tive electrocardiographic (ECG) gating [11]. Steady-state free
precession (SSFP) cine images were acquired in 2-, 3- and 4-
chamber views to plan a stack of 8-mm short-axis slices with a
2-mm interslice gap, spanning the cardiac apex through the
ventricular base. Imaging parameters as detailed in Table 1
were optimised with a minimal field of view to achieve a
typical in-plane spatial resolution <2 mm and temporal reso-
lution <50 ms. Radiofrequency tagging by a spatial modula-
tion of magnetization (SPAMM) sequence with gradient
recalled-echo readout was applied at basal, mid-ventricular
and apical levels, typically achieving temporal resolution
<40 ms. Multi-plane localizer images were used to plan an
oblique sagittal SSFP cine of the ascending and descending
aorta. An axial SSFP cine was acquired at the level of the
pulmonary artery bifurcation to allow assessment of aortic
distensibility. An orthogonal high temporal resolution (<10
ms) through-plane velocity-encoded sequence was acquired
to allow assessment of pulse-wave velocity.
Body composition
Volume status was assessed by segmental multiple-frequency
bioelectrical impedance measurements, using tetrapolar 8-
point tactile electrodes (InBody S20, Biospace, Seoul, South
Korea) [12]. Hypervolemia was estimated by the ratio of ex-
tracellular water to total body water [13].
Biochemical markers
Serum samples for determination of high-sensitivity troponin-T
and NT-proBNP were taken immediately after insertion of ac-
cess needles on HD on the day preceding the CMR study. Sam-
ples were promptly centrifuged and analysed using the Elecsys
2010 system (Roche Diagnostics, Switzerland). The limits of
detection of the troponin-T assay are 0.005 μg/L, the 99th per-
centile 0.014μg/L and the 10% co-efficient of variation is 0.013
μg/L [14]. The limits of detection of the NT-proBNP assay is 0.6
pmol/l and the interassay co-efficient of variation is 3.9 %.
Table 1 Typical CMR acquisition parameters






Respiratory compensation breath-hold breath-hold breath-hold free breathing
Acquisition time (s) 12–18 12–18 12–18 240–360
ECG gating retrospective retrospective retrospective retrospective
TR: repetition time (ms) 3.2 6.7 3.2 6.7
TE: echo time (ms) 1.7 3.1 1.7 4.5
Voxel size (mm) 1.7×1.7×8 1.7×2.4×10 1.3×2.5×5 1.3×2.5×5
Slice thickness (mm) 8 10 5 5
Interslice gap (mm) 2 6–12 NA NA
Typical field-of-view (mm) 380 380 320 320
Matrix 224×224 224×160 256×128 256×128
Parallel imaging enabled enabled enabled enabled
View-sharing Yes Yes Yes Yes
Flip angle (degrees) 60 12 60 30
Number of signal averages 1 1 1 4
Lines per segment 16 10 16 1
Reconstructed phases 30 30 30 100
Temporal resolution (ms) 20–50 20–40 20–50 <10
VENC (cm/s) 150–200
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Data analysis
All CMR analyses were performed offline in a blinded fashion.
End-systolic and end-diastolic LV volumes and end-diastolic
LV mass were determined using cvi42 software, version 4.0.2
(Circle Cardiovascular Imaging, Calgary, Canada). The LV
contours were drawn manually excluding papillary muscles
and trabeculations in accordance with previously validated
methods proven to be more reproducible than alternative tech-
niques [6, 15]. LV mass was calculated by taking the difference
between the end-diastolic endocardial and epicardial volume
multiplied by 1.05 g/mL, which is the density of myocardium.
LV concentric remodelling was determined by the LV mass/
volume ratio where a higher ratio corresponds to greater con-
centric remodelling. Values were indexed to body surface area
using the method described by Mosteller [16].
Strain analysis
Tagged LV short-axis images were analysed using validated
software as previously described [17]. The process is depicted
in Fig. 1. Peak-systolic strain (PSS), peak-systolic strain-rate
(PSSR) and peak diastolic strain-rate (PDSR) were deter-
mined. The standard deviation of segmental time-to-peak
strain (SD-TTP) normalised to a heart rate of 70 beats per
minute was calculated as a measure of LV dyssynchrony as
previously described [18]. Data were analysed in the 16-
segment LV model recommended by the American Heart As-
sociation and averaged per short-axis slice and across all seg-
ments to determine global LV strains [19] (Fig. 1).
Aortic distensibility
The ascending and descending aortas were manually outlined
with semi-automated propagation into all cardiac phases using
the Jim software package (version 6, Xinapse Systems, UK).
Aortic distensibility was calculated from the SSFP cines as
(maximum aortic area – minimum aortic area) / (minimum
aortic area x ΔP), where ΔP is the average of three brachial
pulse pressure readings performed during CMR (Fig. 2) [20].
Aortic arch pulse wave velocity (PWV) was calculated as the
distance around the arch between the ascending and
Fig. 1 LV circumferential strain analysis in a typical study participant.
Tagged LV short-axis images had manual endocardial and epicardial bor-
der tracing in a single frame, with automated propagation of the contours
to all other frames to generate LV segmental strain curves (B) recording
both peak strain and the time-to-peak strain (dotted lines, B). Segmental
strains were averaged to determine global LV strain (C) and strain-rate
(D) curves from which peak-systolic and diastolic values were used as
study outcomes
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descending aorta positions in the axial slice, divided by the
time delay for arrival of the pulse pressure wave between these
positions (Fig. 3) [21]. The distance around the arch was
assessed from an oblique sagittal view, and the time delay
was calculated using cross-correlation of the flow velocity
profiles generated by the velocity-encoded acquisition
(Fig. 3a, d).
Statistical analysis
Continuous data were tested for normality and summarized
using mean±SD or median [25th, 75th percentile]. Differ-
ences between groups were determined using the Mann-
Whitney or t-test as appropriate. Categorical data were
expressed as counts and percentages and analysed by the
Chi-squared test. Continuous variables with right-skewed dis-
tributions were logarithmically transformed prior to applying
Pearson’s test to assess relationships between continuous var-
iables. The Benjamini and Hochberg procedure constrained
the study-wise false discovery rate to a two-sided significance
of 0.05 with adjusted P values presented [22]. SPSS version
21.0 was used for all analyses.
Results
The participant flowchart is in Fig. 3. Eighty-three participants
were studied; 54 patients within 6 months of commencing HD
and 29 age- and sex-matched healthy volunteers. The causes of
end-stage renal disease in HD patients were diabetes mellitus 17
% (14/54); glomerulonephritis 8 % (7/54); interstitial nephritis 7
% (6/54); vasculitis 5 % (4/54); polycystic kidney disease 4 %
(3/54); ischemic nephropathy or malignant hypertension 7% (6/
54); light chain deposition disorder 5 % (4/54) and unknown or
others 12 % (10/54). Subject characteristics and CMR findings
are presented in Table 2. The groups were well matched for age,
sex, body mass index, body surface area, and smoking status.
Most HD patients were treated for hypertension (78 %, 42/54)
and 26 % (14/54) were treated with a renin-angiotensin-
aldosterone system antagonist.
Image quality
Eight HD patients did not tolerate long breath-holds and were
managed by minimising the field of view and increasing the
lines per segment to allow a breath-hold less than 15 seconds.
Only 1 HD patient had significant arrhythmia which was
Fig. 2 Determination of aortic
distensibility in the same study
participant as in Figure 2. An
oblique sagittal image of the tho-
racic aorta (A) was used to deter-
mine the pulse-wave propagation
distance (solid line, A) at the level
of the right pulmonary artery
(dotted line, A). Orthogonal axial
SSFP cines (B) and velocity
encoded images (C) were used to
contour the ascending and de-
scending aorta to derive traces of
aortic area (upper panel inD) and
aortic blood flow (lower panel in
D) versus time. Aortic distensi-
bility was determined by dividing
the maximal area change by
pulse-pressure. Aortic arch pulse
wave velocity was calculated by
dividing the pulse-wave propaga-
tion distance by the transit delay
between these positions deter-
mined by cross-correlation of the
flow velocity profiles (lower
panel in D)
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managed by increasing the arrhythmia rejection window and
prospective ECG gating. All cases were of diagnostic quality
as assessed by an experienced CMR operator.
Global systolic and diastolic function
Global LV systolic function was reduced in HD patients both
by EF and PSS (EF 51.5 % ±11.0 in HD patients versus 58.5
% ±5.4 in control subjects, p<0.001; PSS 15.9 % ±3.7 versus
19.5 % ±3.3, p<0.001). Systolic function by global PSS was
inversely correlated to LV dyssynchrony (r=-0.51, p<0.001),
concentric remodelling (r=-0.37, p=0.005) and troponin-T
(r=-0.41, p=0.03). Diastolic function was reduced in HD pa-
tients (PDSR 1.07±0.33 s-1 in HD patients versus 1.31±0.38
s-1 in control subjects, p=0.003). Diastolic function was in-
versely correlated to LV dyssynchrony (r=-0.51, p<0.001),
concentric remodelling, aortic PWV (r=-0.48, p=0.04) and
age (r=-0.31, p=0.02).
LV mass and geometry
LV mass was increased in HD patients, (63 [54, 79] versus 46
[42, 53] g/m2, p<0.001) with greater LV concentric remodel-
ling (LV mass/volume ratio 0.76 [0.64, 0.86] versus 0.65
[0.55, 0.71], p=0.001, Table 2).
Regional heterogeneity of LV strain
Systolic function by PSS was significantly reduced in bas-
al, mid-cavity and apical short-axis slices in HD patients
compared to NCs (Table 2). Significant regional reductions
in PSS in HD patients were seen in 7 of 16 LV segments,
Assessed for eligibility 
(n=223)
Excluded  (n=150)
29 did not meet inclusion criteria
121 declined to participate due to 
inconvenience/disinterest
Enrolled to study (n=73)
Did not complete CMR 
(n=19) 
5 withdrawal of consent 
5 did not tolerate CMR
2 deaths
2 intercurrent illness
2 too obese for CMR
1 unable to verify CMR safety
1 pregnancy after enrolment
1 relocation out of area
CMR acquired (n=54)
CMR analysed (n=54)  
Assessed for eligibility 
(n=56)
Excluded  (n=23)
3 did not meet inclusion criteria
20 declined to participate due to 
inconvenience/disinterest
Enrolled to study (n=36)
Excluded from analysis for incidental 
findings (n=2)
1 valvular disease
1 unrecognized myocardial infarction
1 withdrawal of consent
Excluded from analysis to achieve 
age and sex-matched cohort (n=4)
CMR analysed (n=29)       
CMR acquired (n=35)
HD patients ControlsFig. 3 Study participant
flowchart
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particularly in the septal and lateral walls (Table 3 and
Fig. 4)
LV dyssynchrony
There was greater LV dyssynchrony in HD patients as
determined by increased dispersion in the time to peak
strain (SD-TTP 56±21 ms vs 39±14 ms, p<0.001,
Table 2). LV dyssynchrony was inversely correlated to
diastolic function by PDSR (r=-0.51, p<0.001) and EF
(-0.45, p=0.001; Table 4).
Aortic distensibility
Aortic distensibility was decreased in HD patients (2.0
[1.3, 3.1] vs. 4.1 [3.1, 6.2], p<0.001) and correlated to
Table 2 Subject characteristics
and CMR parameters HD (n=54) Controls (n=29) p value
Age (years) 57±15 56±17 0.7
Female (%) 15 (28) 8 (28) 1
Anthropometric variables
Body mass index (kg/m2) 28±6 27±3 0.5
Body surface area(m2) 1.9±0.2 1.9±0.2 0.9
Medical history
Time since commenced HD (days) 94±84
Diabetes mellitus (%) 14 (26) 2 (7)
Ischaemic heart disease (%) 13 (24) 0 (0)
Current/ex-smoker (%) 25 (46) 8 (28)
Peripheral vascular disease/stroke (%) 7 (13) 0 (0)
LV systolic dysfunction (%) 4 (7) 0 (0)
Medication
Treated hypertension (%) 42 (78) 2 (7)
RAAS antagonist (%) 14 (26) 1 (3)
Beta blocker (%) 19 (35) 0 (0)
Other antihypertensive (%) 37 (69) 2 (7)
Statin use (%) 23 (43) 4 (14)
CMR parameters
Global peak systolic strain (%) 15.9±3.7 19.3±3.4 <0.001
Basal peak systolic strain (%) 14.5±3.8 18.4±4.5 <0.001
Mid-ventricular peak systolic strain(%) 16.2±4 20±4.2 <0.001
Apical peak systolic strain (%) 16.9±4.1 19.7±3.4 0.002
Peak diastolic strain rate (s-1) 1.07±0.33 1.31±0.38 0.003
Peak systolic strain rate (s-1) 1.03±0.22 1.28±0.24 0.006
LV dyssynchrony by SD-TTP (ms) 56±21 39±14 <0.001
LVend-diastolic volume index (ml/m2)* 88±23 75±14 0.002
LV stroke volume index (ml/m2)* 44±12 44±9 0.8
LV ejection fraction (%) 51±10 59±5 <0.001
LV mass index(g/m2)* 63 [54, 79] 46 [42, 53] <0.001
LV mass/volume ratio (g/ml) 0.76 [0.64, 0.86] 0.65 [0.55, 0.71] 0.001
Aortic distensibility (mmHg−1×10−3) 2 [1.3, 3.1] 4.1 [3.1, 6.2] <0.001
Aortic pulse wave velocity (m/s) 7.9±3.5 5.3±1.9 0.03
Systolic blood pressure (mmHg) 143±27 139±18 0.6
Diastolic blood pressure (mmHg) 76±12 80±10 0.2
Pulse pressure (mmHg) 61 [50, 79] 60 [48, 68] 0.3
Categorical data are displayed as counts (percentages). Continuous data were tested for normality and summa-
rized as mean±SD or median [25th, 75th percentile]. HD, haemodialysis; LV, left ventricular; RAAS, renin-
angiotensin aldosterone system; SD-TTP standard deviation of time-to-peak strain.*Values indexed to body
surface area.
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PSS (r=0.37, p=0.047), PSSR (r=0.43, p=0.02), high-
sensitivity troponin-T (r=-0.53, p=0.004) and concentric
remodelling (r=-0.42, p=0.02, Table 4). Aortic pulse
wave velocity was increased in HD patients (7.9±3.5
versus 5.3±1.9 m/s, p<0.001).
Subgroup of HD patients with normal EF
In the subset of HD patients with preserved EF>50% (n=35),
aortic distensibility was still reduced (2.6 [1.9, 4.8] mmHg−1×
10−3 versus 4.1 [3.1, 6.2] mmHg−1×10−3), LV mass remained
increased (63 [55, 79] g/m2 versus 46 [42, 53] g/m2, p<
0.001), PSS was reduced (17.5±3.1 % versus 19.3±3.4 %,
p=0.03), PDSR was reduced (1.10 [0.83, 1.31] s-1 versus
1.27 [1.04, 1.41] s-1, p=0.03), and dyssynchrony remained
greater (SD-TTP 51±18 ms versus 39±14 ms, p=0.006;
Table 5 and Fig. 5).
Subgroup of HD patients with diabetes, ischemic heart
disease or LV dysfunction
To account for the confounding of pre-existing cardiovascular
co-morbidities, we conducted subgroup analyses amongst HD
patients categorised by presence or absence of diabetes, ische-
mic heart disease, prior LV dysfunction, and use of a beta-
blocker or renin-angiotensin aldosterone system antagonist.
These results are detailed in Supplemental Table 1. As adverse
changes were notable amongst HD patients with diabetes, we
compared CMR parameters in non-diabetic HD patients (n=
40) to non-diabetic controls (n=27). Abnormalities such as
reduced systolic strain, increased LV mass and reduced aortic
distensibility remained apparent in HD patients without dia-
betes (Supplemental Table 2).
Discussion
We report the first study using tagged CMR in patients within
6 months of commencing HD, characterising abnormalities in
cardiac size, geometry and strain in terms of magnitude, rate
and synchronicity. The high prevalence of reduced systolic
and diastolic strain (despite preserved EF), ventricular
dyssynchrony, anteroseptal segmental dysfunction and re-
duced aortic distensibility was more evident with the detailed
methods utilised. The relative lack of correlation between
bioimpedance-measured volume status and LV strain was
consistent with volume-independent mechanisms playing a
role in the evolution of cardiac dysfunction in this setting.
Fig. 4 Comparisons of regional PSS using the 16-segment model of the
left ventricle. Segments with significantly lower PSS in HD patients com-
pared to age-matched controls are graphically highlighted
Table 3 Comparisons of
regional peak systolic
strain (%) using the 16







HD NC p value
1 Basal Anterior 13.7±5.7 15.1±5.8 0.3
2 Basal Antero-septal 9.6±5.2 13.5±4.8 0.001
3 Basal Infero-septal 11.3±5.1 12.2±4.7 0.4
4 Basal Inferior 14.7±6.8 16.8±5.4 0.2
5 Basal Infero-lateral 20.6±6.8 24.5±5.8 0.01
6 Basal Antero-Lateral 18.5±5.6 22.5±5.6 0.003
7 Mid Anterior 18.8±5.6 21.6±4.3 0.02
8 Mid Antero-septal 14.3±5.5 18.0±4.5 0.003
9 Mid Infero-septal 13.3±5.2 18.0±3.5 <0.001
10 Mid Inferior 17.4±6.4 20.0±4.9 0.05
11 Mid Infero-lateral 23.3±6.4 24.4±3.5 0.4
12 Mid Antero-Lateral 19.3±4.9 21.4±3.8 0.05
13 Apical Anterior 17.5±4.9 18.6±4.2 0.3
14 Apical Septal 14.7±5.3 18.0±4.1 0.003
15 Apical Inferior 17.9±6.4 20.4±6.7 0.07
16 Apical Lateral 20.2±5.4 20.7±4.8 0.6
Segments with significantly lower PSS in HD patients compared to age-matched controls are graphically highlighted
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These data support and extend previous CMR-based de-
scriptions of cardiomyopathy in established HD patients. Sep-
arate reports characterised different aspects of cardiac and aor-
tic function; however, such a comprehensive assessment in
incident HD patients has rarely been reported. Mark and co-
workers reported gadolinium contrast-enhanced CMR data in
134 prevalent HD or peritoneal dialysis patients selected for
cardiovascular screening for potential renal transplantation.
They reported a prevalence of 72 % for LV hypertrophy and
8.2 % for reduced EF, using cut-offs derived from published
reference range studies. They also found heterogeneity in the
distribution of focal myocardial fibrosis as determined by
gadolinium-based contrast enhancement. The study was con-
ducted prior to awareness of the association of gadolinium
contrast media with nephrogenic systemic fibrosis and did
not investigate strain or relationships to troponin-T. Their find-
ings were concordant with our study, demonstrating lower EF
and greater LV mass in HD patients with regional heteroge-
neity in strain. The differences between these prior studies and
the present might be explained by differences in the popula-
tions studied and exposure to HD.
There are no prior studies of LV strain by CMR tagging in
HD patients, which is currently the reference standard tech-
nique for LV deformation. This present study reports strain
values for the age and sex-matched controls without kidney
disease (19.5±3.3 %) in keeping with reported reference
ranges for circumferential strain by tagged CMR in healthy
volunteers of 16–19 % [23]. Strain values by tagged CMR
may not be directly comparable to studies using tissue Dopp-
ler or speckle-tracking echocardiography. In general popula-
tion studies, absolute differences of 10–25 % against a tagged
CMR reference measure are reported, with wider disparities in
disease states.
Ventricular morphology
Hypertrophy of the LV is an established feature of cardiomy-
opathy in HD patients, representing a maladaptive response
that allows for normal EF despite abnormal pressure or vol-
ume load. In addition to traditional atherosclerotic risk factors,
multiple factors are contributory, including aortic stiffness,
volume and pressure overload, hyperphosphatemia and neu-
rohormonal activation [24]. Recent work has extended this
picture with the implication of locally generated steroids and
fibroblast growth factor 23, both of which are increased in HD
patients [25, 26]. In particular, sodium can induce adrenal
secretion of digitalis-like steroids to produce myocyte hyper-
trophy independent of blood pressure or volume effects,
representing a novel mechanism linking dietary or dialysate
sodium to LV hypertrophy in HD patients [27]. In the present
Table 4 Correlation coefficients of systolic strain, diastolic strain-rate, LV dyssynchrony and aortic distensibility to potential determinants in HD
patients
CMR Parameter PSS PDSR SD-TTP Aortic distensibility
r-value p value r-value p value r-value p value r-value p value
Peak diastolic strain rate 0.56 <0.001 - - -0.51 <0.001 0.3 0.1
LV dyssynchrony by SD-TTP -0.51 <0.001 -0.51 <0.001 - - -0.25 0.2
LV ejection fraction 0.54 <0.001 0.34 0.01 -0.45 0.001 0.22 0.3
Global peak systolic strain rate 0.53 <0.001 0.6 <0.001 -0.35 0.01 0.43 0.02
LV mass index -0.19 0.2 -0.1 0.5 0.18 0.2 -0.24 0.2
LV end-diastolic volume Index 0.02 0.9 0.14 0.3 0.10 0.5 0.10 0.6
LV mass/volume ratio (g/ml) -0.37 0.005 -0.30 0.03 0.19 0.2 -0.42 0.02
Global peak systolic strain - - 0.56 <0.001 -0.51 <0.001 0.37 0.05
Aortic distensibility§ 0.37 0.047 0.3 0.1 -0.25 0.2 - -
Aortic pulse wave velocity 0.01 0.9 -0.48 0.04 0.27 0.3 -0.69 0.001
Biochemical markers
High-sensitivity troponin-T§ -0.41 0.03 -0.18 0.4 0.37 0.06 -0.53 0.004
NT-Pro-BNP§ -0.20 0.2 -0.26 0.08 0.04 0.8 -0.15 0.4
Demographic variables
Age -0.24 0.08 -0.31 0.02 0.07 0.6 -0.73 <0.001
Anthropometric variables
Body mass index -0.12 0.4 0.05 0.7 -0.08 0.6 -0.09 0.6
Body surface area -0.24 0.08 0.03 0.8 0.24 0.09 -0.06 0.8
ECW/TBW§ -0.26 0.1 -0.18 0.3 -0.03 0.8 -0.28 0.2
§ Log-transformed data
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Age (years) 55±16 56±17 0.9
Female (%) 9(26%) 8(28%) 1
Anthropometric variables
Body Mass Index (kg/m2) 28±6 27±3 0.4
Body surface area (m2) 1.9±0.2 1.9±0.2 0.9
Extracellular water/Total body water ratio 0.39 [0.38, 0.40]
Medical history
Time since commenced HD (days) 98±53
Diabetes mellitus (%) 6 (17) 2 (7)
Ischaemic heart disease (%) 9 (26) 0 (0)
Current/Ex-smoker (%) 15 (43) 8 (28)
Peripheral vascular disease/Stroke (%) 4 (11) 0 (0)
LV systolic dysfunction (%) 3 (9) 0 (0)
Medication
Treated hypertension (%) 29 (83) 2 (7)
RAAS antagonist (%) 12 (34) 1 (3)
Beta blocker (%) 15 (43) 0 (0)
Other antihypertensive (%) 25 (71) 2 (7)
Statin use (%) 15 (43) 4 (14)
Biochemical markers
High-sensitivity troponin-T ( μg/L) 27 [13, 54]
NT-pro-BNP (pg/ml) 143 [60, 513]
CMR parameters
Global peak systolic strain (%) 17.5±3.1 19.3±3.4 0.03
Basal peak systolic strain (%) 16.2±3.4 18.4±4.5 0.04
Mid-ventricular peak systolic strain (%) 18.0±3.4 20.0±4.2 0.05
Apical peak systolic strain (%) 18.2±3.9 19.7±3.4 0.1
Peak diastolic strain rate (s-1) 1.10 [0.83, 1.31] 1.27 [1.04, 1.41] 0.03
Peak systolic strain rate (s-1) -1.05 [-1.23, -0.89] -1.27 [-1.40, -1.12] <0.001
LV dyssynchrony by SD-TTP (ms) 51±18 39±14 0.006
LVend-diastolic volume index (ml/m2)* 85±21 75 (14) 0.04
LV stroke volume index (ml/m2)* 48±11 44 (9) 0.2
LV ejection fraction (%) 56±5 59 (5) 0.01
LV mass index(g/m2)* 63 [55, 79] 46 [42, 53] <0.001
LV mass/volume ratio (g/ml) 0.77 [0.68, 0.86] 0.65 [0.55, 0.71] <0.001
Aortic distensibility (mmHg−1×10−3) 2.6 [1.9, 4.8] 4.1 [3.1, 6.2] 0.04
Aortic pulse wave velocity (m/s) 7.0±3.6 5.3±1.9 0.2
Systolic blood pressure (mmHg) 137±23 139±18 0.7
Diastolic blood pressure (mmHg) 74±14 80±10 0.08
Pulse pressure (mmHg) 57 [49, 76] 60 [48, 68] 0.8
Categorical data are displayed as counts (percentages). Continuous data were tested for normality and summarized as mean±SD or median [25th, 75th
percentile]. HD, hemodialysis; LV, left ventricular; RAAS, renin-angiotensin aldosterone system; SD-TTP, standard deviation of time-to-peak
strain.*Values indexed to body surface area.
ECW/TBWextracellular water/total body water by bioimpedance
NT-pro-BNP N-Terminal Pro-B-type natriuretic peptide
RAAS Renin-angiotensin aldosterone system
SD-TTP standard deviation of the segmental time to peak circumferential strain
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study, LV concentric remodelling by mass/volume ratio was
significantly increased in HD patients compared to controls,
even amongst those with preserved EF or without diabetes.
Heterogeneity of systolic strain
The regional heterogeneity of PSS has not previously been
described in HD patients. In studies of hypertensive cardio-
myopathy, tagged CMR demonstrated the earliest effects of
pressure overload by basal septal reductions in PSS and PSSR
[28]. This is in contrast to infiltrative genetic disorders such as
Fabry’s disease where the earliest reductions in PSS are seen
in inferolateral segments [29]. The present study reports re-
ductions in the entire septum, as well as anterolateral seg-
ments. This supports the notion that HD might be associated
with a distinct cardiomyopathy, reflecting several remodelling
signals, some of which are independent of pressure or volume,
including recurrent HD ischemic insults [24, 30].We observed
significant correlations of PSS to LV dyssynchrony, concen-
tric remodelling, aortic distensibility, aortic stiffness and high
sensitivity troponin-T.
Diastolic function
The determinants of diastolic function in HD patients are not
well described, despite an increasing appreciation of the prog-
nostic importance of this form of ventricular relaxation defect.
Using speckle tracking echocardiography, De Bie and co-
workers reported univariate determinants as LVmass, concen-
tric remodelling and PWV [31]. Losi and co-workers found a
significant relationship of diastolic dysfunction in HD patients
to echocardiographic-integrated backscatter (as a surrogate for
myocardial fibrosis) [32]. We additionally report significant
relationships to LV dyssynchrony and age.
Synchronicity and coherence of ventricular contraction
Synchronous contraction of the LV is essential to efficient
cardiac output. LV dyssynchrony by tagged CMR has not
previously been described in HD patients; in other settings,
good reproducibility, preload independence and the ability to
predict benefit from resynchronisation therapies have been
demonstrated [18, 33]. El Ghannudi and co-workers reported
SD-TTP of 28.5±11.5 ms in control subjects and 91.3±25 ms
in patients with EF<55 % due to ischemic or dilated cardio-
myopathy. This compares with 39±14 ms in control subjects
and 56±21 ms in HD patients in the present study. LV
dyssynchrony was positively correlated to PSS and inversely
correlated to diastolic function by PDSR (r=-0.51, p<0.001)
and EF (-0.45, p=0.001). This study is the first to link LV
dyssynchrony and diastolic dysfunction in HD patients.
Aortic distensibility
Aortic distensibility was reduced in HD patients and this pat-
tern persisted in the subgroup of HD patients with preserved
EF or without diabetes. Reported values are consistent with
prior studies [34]. In the present study, the strong correlation
of aortic distensibility to troponin-T (r=-0.53, p=0.004) is
novel. Troponin-T reflects the presence and severity of HD-
induced ischemia [35], and is potentially aggravated by the
increased risk of demand ischemia resulting from reduced
aortic distensibility causing reduced diastolic coronary blood
flow [36]. Given that we examined an incident population









Fig. 5 Boxplots of Global PSS and LV dyssynchrony by SD-TTP stratified by EF
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likely that the changes we saw in HD patients occurred, at
least in part, prior to commencing HD. Edwards et al. com-
pared aortic distensibility by CMR in patients with CKD stage
3 to normal controls [37]. They derived similar values to the
present study (2.2±1.8 in CKD vs. 4.1±1.3 mmHg−1×10−3 in
controls) compared with 2.0 [1.3, 3.1] vs. 4.1 [3.1, 6.2] in the
present study).
Volume status
Biomarkers of volume status (ECW/TBW, LV end-diastolic
volume index and NT-pro-BNP) showed no significant corre-
lations to systolic strain, diastolic strain rate, LV dyssynchrony
or aortic distensibility. This might indirectly represent
volume-independent influences on cardiac function in HD
patients.
Limitations
Although we have examined associations, the cross-sectional
design limits our ability to determine any causal relationships.
In particular, a longitudinal study design would be a better
design to assess the impact of HD on the natural history of
cardiomyopathy. Circumferential strain is reported, but the
lack of longitudinal strain is a limitation. Furthermore, we
did not have a CKD or treated hypertension control group
and, thus, cannot determine the extent of their relative contri-
butions to the observed between group differences. This could
be addressed by a longitudinal study design from early-stage
CKD through to HD, but as most patients with CKD do not
progress to end-stage kidney disease [38], such a study would
be prohibitively large. An alternative longitudinal studies
amongst matched groups with hypertension, CKD and inci-
dent HD. Such a study might still have residual confounding
that might not entirely be removed by statistical methods.
Conclusion
This study provides the first data comprehensively
characterising LV strain, dyssynchrony and aortic distensibil-
ity by tagged CMR imaging in patients new toHD, revealing a
greater degree of cardiac dysfunction than previously recog-
nized. These abnormalities still persisted in HD patients with
preserved EF or without diabetes. This reinforces the need to
proactively engage in cardio-protective strategies and stresses
the particular potential of dialysis therapy-based interventions.
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